Leptin, an adipokine upregulated during obesity, has been widely studied in carcinogenesis because of its many signalling pathways [4] involved in critical steps of pathogenesis such as cell proliferation [5, 6], inflammatory response [7] and modulation of the tumour environment [8]. This evidence concerns the gene LEP and obesity disorder.